SAFETY OF CELL-BASED THERAPIES IN CLINICAL TRIALS FOR KIDNEY DISEASES: A SCOPING REVIEW

https://storage.unitedwebnetwork.com/files/1099/c1c0cec86b2c4beaa359e0d5015cda6c.pdf
SAFETY OF CELL-BASED THERAPIES IN CLINICAL TRIALS FOR KIDNEY DISEASES: A SCOPING REVIEW
Irene
De Lourdes Noronha
David Gerber griessgerb2@gmail.com The University of North Carolina at Chapel Hill Surgery Chapel Hill
Joseph Stavas joseph.stavas@prokidney.com ProKidney Clinical Development Raleigh
Maria Diaz Gonzalez de Ferris maria_ferris@med.unc.edu The University of North Carolina at Chapel Hill Pediatrics Chapel Hill
LaTonya Hickson Hickson.Latonya@mayo.edu Mayo Clinic Medicine Jacksonville
Guido Filler guido.filler@rogers.com Western University, Schulich School of Medicine and Pediatrics Pediatrics London
Rupesh Raina RRaina@akronchildrens.org Akron Nephrology Associates/Cleveland Clinic Akron General Medical Center Nephrology Akron
Nuria Maria Pastor-Soler Nuria.Pastor-Soler@med.usc.edu University of Southern California, Keck School of Medicine Medicine Los Angeles